NewGenIvf Group

What NewGenIvf Group does

NewGenIvf Group Limited (NASDAQ: NIVF) is a diversified healthcare and technology platform headquartered in Hong Kong with core operations based in Bangkok. The company's foundational business is assisted reproductive services delivered through its First Fertility clinic network (primarily Kyrgyzstan-sourced revenue with medical tourism flows), augmented by proprietary MicroSort cytometry-based sperm sorting technology acquired in 2025 alongside the Nodexus business, with intellectual property valued at approximately $17.9 million and a $19.2 million bargain purchase gain recognized. The MicroSort platform operates alongside a direct-to-consumer wellness supplements e-commerce brand (NewGenSup).

The company has executed a pronounced strategic pivot beyond fertility into digital asset infrastructure and real estate development. It operates NewGenDigital for tokenization services, partnering with Evident Capital's SFC-licensed Hong Kong platform to issue up to $30 million in tokenized real estate bonds referencing its Ras Al Khaimah UAE residential project (adjacent to Wynn Al Marjan Island casino resort, projected $123 million pre-tax profits on 2028 completion). The company adopted a Digital Asset Treasury strategy in 2026 (binding term sheet for over $110 million of Solana with White Lion Capital; Bitcoin accumulation) and acquired a 10% stake in AI-native prediction market platform K25.ai at a $100 million valuation, securing exclusive APAC agency rights. A proposed reverse merger with SAXA, Inc. (mining assets valued at approximately $11 billion) was announced in November 2025.

Revenue is generated across professional services (fertility procedures), licensing (MicroSort technology), e-commerce (supplements), transaction fees (5% commissions on tokenized assets and tokenized bond issuance), affiliate/referral income (K25.ai APAC agency), and one-time real estate license revenue. The primary customer segments are fertility patients (B2C, with medical tourism), health-conscious consumers, high-net-worth real estate investors (including Golden Visa seekers), digital asset investors, and APAC prediction market participants. FY2025 revenue was approximately $4.73 million against a net profit of $9.9 million (largely bargain purchase gain), with total assets of $32.7 million as of December 31, 2025 and a market capitalization of approximately $7.6 million against net asset value of approximately $25.98 million.

Name

NewGenIvf Group

Legal name

NewGenIVF Group Limited

Website

https://newgenivf.com

Company type

Public

Founded year

2021

Operating status

Operating

Headcount range

51–100 employees

Short description

NewGenIvf Group (NASDAQ: NIVF) is a diversified Hong Kong-headquartered platform operating fertility clinics, proprietary MicroSort sperm-sorting technology, digital asset tokenization services, and a UAE residential real estate project adjacent to Wynn Al Marjan Island.

Ownership category

akta.pro rank

Product category

Assisted Reproductive Services and Fertility Healthcare

NAICS

Family Planning Centers (621410)

SIC

Land Subdividers & Developers (No Cemeteries) (6552), Investment Advice (6282)

akta.pro primary industry

Fertility, Reproductive Endocrinology & IVF Centers (HLAFAJAD)

akta.pro secondary industry

Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening) (HLAAALAJ)

Keywords

• Assisted reproductive services
• Fertility treatments
• Sperm sorting technology
• Digital asset tokenization
• Wellness supplements

Headquarters

HQ city

Central

HQ country

Hong Kong SAR China

HQ region

Asia

Offices4 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure, Others

Revenue model

1. Assisted Reproductive Services: IVF clinic operations providing fertility treatments and services. Revenue derived from medical procedures, consultations, and related healthcare services. The Bangkok-based company derives most revenue from Kyrgyzstan operations while expanding into Dubai.
2. Microsort Technology Licensing: Cytometry-based sperm sorting technology licensing and related services. Following the acquisition of Nodexus and Microsort businesses with associated IP valued at $17.9 million, the company generates revenue through technology deployment in fertility clinics.
3. Wellness Supplements: Sale of wellness supplements through NewGenSup e-commerce platform. Consumer wellness products marketed directly to customers seeking health and fertility-related nutritional support.
4. Digital Asset Management and Tokenization: Digital asset treasury strategy and tokenization services. Revenue generated through agent commissions (5% on tokenized assets sold), advisory fees, and digital asset accumulation strategy. Includes tokenized bond issuance and gold-backed asset tokenization.
5. Tokenized Bond Issuance: Non-dilutive, debt-style tokenized structures to fund business growth. Up to USD 30 million in tokenized bonds planned, referencing UAE real estate projects. Professional investors subscribe through regulated tokenization platforms.
6. APAC Agency and Distribution Rights: Exclusive APAC commercial agent partnership for K25.ai, earning commission on gross profit from customers introduced or serviced in selected markets including Thailand, Singapore, Japan, Australia, and New Zealand.
7. Real Estate Development: Ras Al Khaimah residential development project adjacent to Wynn Al Marjan Island casino resort. Revenue from property sales, leasing management, and value-added services. Projected pre-tax profits of $123 million upon conversion to joint development structure, targeting 2028 completion.

Pricing tiers

Go-to-market motion3 records

Distribution channels5 records

Marketing channels5 records

Core offering

NewGenIVF Group is a diversified healthcare and technology platform that provides IVF and assisted reproductive services through First Fertility clinics, proprietary MicroSort cytometry-based sperm sorting technology for fertility treatments, women's wellness supplements through NewGenSup e-commerce, and digital asset tokenization services through NewGenDigital. The company also operates a UAE residential real estate project in Ras Al Khaimah and holds a strategic equity stake and exclusive APAC agency rights in the AI-powered K25.ai prediction market platform.

Product overview

NewGenIVF Group operates as a diversified platform with four main business segments: Assisted Reproductive Services (First Fertility clinics), MicroSort (cytometry-based fertility technology), Supplement (NewGenSup wellness products), and Web 3 Solutions (digital asset/tokenization services). The company has expanded beyond healthcare into real estate development (RAK Residence Project) and strategic investments in AI platforms (K25.ai prediction market).

Differentiator

Problem solved

Functional benefit

Brands

• First Fertility: Assisted reproductive services and fertility treatments
• MicroSort
• NewGenSup
• NewGenDigital
• RAK AI Marjan Island

Products and services

• First Fertility IVF and Assisted Reproductive Services IVF and fertility treatment services provided through First Fertility clinics, including fertility preservation, genetic testing, and egg freezing for individuals and couples including international medical tourism patients.
• MicroSort Sperm Sorting Technology Advanced cytometry-based sperm sorting technology for gender selection and fertility treatments, supported by proprietary intellectual property and used to support fertility clinic operations.
• NewGenSup Wellness Supplements Consumer wellness supplement products supporting reproductive health and overall wellness, sold direct-to-consumer through the NewGenSup e-commerce platform.
• NewGenDigital Tokenization Services Digital asset management and tokenization services including tokenization of real estate, gold-backed assets, and art collections, plus digital asset treasury strategy accumulating Bitcoin and Solana as long-term reserves.
• RAK Residence Project (Ras Al Khaimah Real Estate Development)

Quantifiable outcome

• $9.9 million net profit in FY2025, up from net loss previously
• +3 more outcomes

Named customers2 records

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature4 records

Partnerships

Four partnerships are on record, tiered core and minor.

• K25.aicoreStrategic or Co-development Partner · 21 May 2026Nasdaq-listed NewGenIVF made an initial $2 million strategic investment in K25.ai at $100 million valuation with option to increase to $10 million. NewGen acquired 2% initial equity stake with rights to increase to 10%, and serves as exclusive APAC commercial agent across Thailand, Singapore, Japan, Australia, and New Zealand. K25.ai is an AI-native livestreaming and watch-to-predict information market platform. By June 2026, NewGen had increased its stake to 10% through additional $4 million investment, completing K25.ai's $10 million Pre-A round. K25.ai founder Andy Cheung joined NewGen's board to lead Digital Asset Treasury Strategy.
• Women in Web3 Hong Kong LimitedminorGTM or Marketing Partner · 2 March 2026NewGenIVF signed a Memorandum of Understanding with Women in Web3 Hong Kong to launch a co-branded public awareness and education campaign focused on women's health literacy. The campaign includes talks, panel discussions, and community events aimed at educating women on family planning, wellness, and informed decision-making. NewGenSup provides wellness supplement insights. Partnership aligns with NewGen's mission to advance women's health while engaging Hong Kong's Web3 innovation community.
• Evident CapitalcoreStrategic or Co-development Partner · 21 January 2026NewGenIVF engaged Evident Capital to support launch of up to USD 30 million tokenized bond program. Evident Capital provides its SFC-licensed Hong Kong-based tokenization platform enabling professional investors to subscribe to tokenized bonds referencing NewGen's UAE residential project in Ras Al Khaimah. The partnership completed its inaugural tokenized bond commitment campaign in under two weeks, representing one of the first examples of UAE real estate bridged into Asian capital markets via regulated institutional-grade tokenization.
• SAXA Inc.coreStrategic or Co-development Partner · 5 November 2025NewGenDigital was appointed by SAXA Inc. as worldwide agent for tokenizing an initial US$100 million of gold-backed assets, with plans to expand to US$1 billion. NewGen earns 5% commission on tokenized assets sold. The agreement supports a proposed reverse merger between the two companies involving mining assets valued at approximately US$11 billion, including gold and silver mines and a rare earth processing facility.

Scale indicators16 records

Recent moves10 records

Expansion highlights6 records

Direct peers

• Virtus Health: Australian publicly listed IVF and fertility services operator with clinics across multiple countries. Direct comparison to NewGenIVF's First Fertility clinic operations, including medical tourism and advanced reproductive technology offerings.
• Monash IVF Group: Asia-Pacific fertility clinic operator providing IVF and assisted reproductive services. Comparable international footprint, medical tourism focus, and genetic testing capabilities similar to NewGenIVF's offerings.
• Genea Biomedx: Developer and manufacturer of IVF technologies and laboratory solutions. Comparable to NewGenIVF's Microsort fertility technology business and clinical workflow products used by fertility clinics.
• Hamilton Thorne: Provider of precision instruments, consumables, and software for the IVF and reproductive science markets. Comparable to NewGenIVF's Microsort sperm sorting technology and IVF lab equipment focus.
• Inception Fertility: US-based fertility clinic operator with multiple clinic brands. Comparable clinic operations model and patient acquisition approach to NewGenIVF's First Fertility business.
• CCRM Fertility: Network of fertility clinics offering IVF and reproductive endocrinology services. Comparable patient-centric fertility treatment model with focus on advanced reproductive technologies.

Broad incumbents

• CooperSurgical: Large established player in fertility and women's health with broad portfolio including IVF media, devices, and genomics. Provides overlapping capabilities to NewGenIVF's Microsort and IVF services across a much wider product portfolio.
• Vitrolife: Global provider of media, equipment, and consumables for assisted reproduction. Comparable to Microsort's role as a fertility technology provider serving clinics rather than operating them.
• FUJIFILM Irvine Scientific: Major supplier of cell culture media and assisted reproductive technology products. Comparable to NewGenIVF's role in providing fertility lab technologies and consumables to clinics.

Emerging players

• Securitize: Tokenization platform for real-world assets including real estate and securities. Comparable to NewGenDigital's tokenization services and tokenized bond offerings through Evident Capital.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries5 records

Funding overview

Funding rounds4 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments3 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NewGenIvf Group